retatrutide approved in other countries UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide, an experimental weight-loss drug,

In contrast to both meta-analyses, we observed a reduction in HDL cholesterol, similar to another study in which 30 obese subjects received subcutaneous semaglutide once weekly at a dose of 1.0 mg or placebo (42)

Skin Type Quick-Reference Table Pro Tip: Don't skip the patch test

Growing research points to gut microbiome dysregulation and impaired gut barrier integrity as contributors to the chronic inflammation seen in PMOS

Junctions between intimately apposed cell membranes in the vertebrate brain

Lack of vitamin D and/or its receptor (VDR) can lead to a series of proinflammatory cytokines, such as TNF- and IFN-, which can weaken the mucosal barrier function, increasing permeability (Reich et al., 2014)